The development of sophisticated pharmaceutical treatments often hinges on the precise synthesis of complex organic molecules. Apremilast, a significant therapeutic agent for inflammatory diseases, is one such molecule whose production relies heavily on specific, high-quality chemical intermediates. Among these, (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine, known by its CAS number 608141-42-0, plays an indispensable role.

This ethoxyphenyl methylsulfonyl ethanamine derivative serves as a critical building block in the multi-step synthesis of Apremilast. The stereochemistry and functional groups present in this methylsulfonyl ethanamine intermediate are meticulously designed to facilitate subsequent reactions, ultimately leading to the formation of the active pharmaceutical ingredient. The efficiency and success of the Apremilast synthesis are therefore directly influenced by the quality and availability of this particular Apremilast intermediate.

Understanding the (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine synthesis is paramount for manufacturers in the pharmaceutical sector. The process typically involves advanced organic chemistry techniques to ensure the correct chiral form and high purity. Companies like NINGBO INNO PHARMCHEM CO.,LTD. specialize in the production of such vital fine chemicals, contributing significantly to the pharmaceutical supply chain. Their expertise in pharmaceutical intermediate manufacturing ensures that critical components like CAS 608141-42-0 are produced to meet the exacting standards required for drug production.

The selection of suppliers for these intermediates is a strategic decision for pharmaceutical companies. Factors such as product purity, batch-to-batch consistency, reliable supply, and competitive pricing are all taken into consideration. By partnering with reputable fine chemical manufacturers, companies can mitigate risks associated with drug synthesis and ensure the uninterrupted production of life-saving medications.

In essence, the story of Apremilast synthesis is also the story of its key intermediates. The reliable provision of high-quality (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine by specialized chemical companies is a testament to the advanced capabilities within the fine chemical industry, enabling the delivery of effective treatments to patients.